Pulmonology

The HCPLive Infectious Disease condition center page is a comprehensive resource for clinical news and insights on respiratory health. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for asthma, COPD, interstitial lung disease, COVID-19, and more.

FDA Grants 510(k) Clearance to Pulsehaler for Respiratory Disease Relief

April 06, 2021

Article

The non-invasive device uses air pressure pulsations to help open airways and provide clearance of secretions in patients with disease such as COPD, asthma, and cystic fibrosis.

What Experts Are Learning About Sotatercept for PAH

April 02, 2021

Video

An interview with a phase 2 investigator on the the novel drug's potential in a field it wasn't originally designed to treat.

Sotatercept Could Be a Promising Novel Agent for Pulmonary Arterial Hypertension

April 01, 2021

Article

New phase 2 data from a 24-week assessment suggest the first-in-class drug could benefit exercise and pulmonary-vascular outcomes.

FDA Approves Treprostinil for Pulmonary Hypertension Linked to Interstitial Lung Disease

April 01, 2021

Article

The supplemental approval for Tyvaso comes on the basis of clinical evidence showing benefit for pulmonary and cardiovascular outcomes in adult patients.

FDA Approves First-Ever Device to Treat Congenital Heart Disease Complications

March 26, 2021

Article

The Harmony Transcatheter Pulmonary Valve System is designed to treat adult and pediatric patients with pulmonary valve regurgitation.

The US Still Has Ground to Make on Tuberculosis

March 24, 2021

Video

On World TB Day, experts from the ALA and CDC reflect on the recent issues of tuberculosis.

The Keys to Eliminating US Tuberculosis

March 24, 2021

Video

In commemoration of World TB Day, a CDC and ALA expert discuss how TB still exists in the country.

The History of Tuberculosis and Future Strategies

March 22, 2021

Podcast

CDC tuberculosis lead Dr. Phillip LoBue joins to discuss the past and present issues of the disease, in time for TB Awareness Day on March 24.

Study Reports on Factors Linked to Severe MIS-C Outcomes

March 10, 2021

Article

Nearly 60% of children with MIS-C are admitted to the hospital for intensive care.

FDA Approves Tocilizumab for SSc Interstitial Lung Disease

March 05, 2021

Article

The indication makes the IL-6 inhibitor the first biologic approved for treating pulmonary function in patients with the rare disease.